At a glance
ClinicalIndex Comparison RecordN/ACompleted· 115 enrolled
Drug / intervention
AcQBlate® Force Sensing Ablation Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
AcQBlate Force Sensing Ablation System US IDE for Atrial Flutter (AcQForce Flutter)
In Brief
A clinical study evaluating AcQBlate® Force Sensing Ablation System for Typical Atrial Flutter. Completed, enrolled 115 participants across 24 sites in 3 countries.
Detailed Summary
The Acutus Medical AcQForce Flutter clinical study is a prospective, multi-center, non-randomized global study designed to demonstrate the safety and effectiveness of the AcQBlate Force Sensing Ablation System in the ablation management of symptomatic cavotricuspid isthmus dependent atrial flutter.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTypical Atrial Flutter
CountriesBelgium, United Kingdom, United States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedDec 2020
Enrollment StartMar 2021
Primary CompletionMay 2022
Study CompletionJun 2022
TodayJul 2026
First PostedDec 9, 2020
Enrollment StartMar 25, 2021
Primary CompletionMay 12, 2022
Study CompletionJun 12, 2022
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 5.6 years ago
Interventions
AcQBlate® Force Sensing Ablation Systemdevice
Percutaneous catheter ablation of the cavotricuspid isthmus